Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Jun 15 2022

Full Issue

Advances In HIV Treatment And Prevention; Prescription Drug Shortages Are Over In Canada

Read about the biggest pharmaceutical developments and pricing stories from the past week in KHN's Prescription Drug Watch roundup.

ScienceDaily: A New Technology Offers Treatment For HIV Infection Through A Single Injection

A new study offers a new and unique treatment for AIDS which may be developed into a vaccine or a one-time treatment for patients with HIV. (Tel Aviv University, 6/14)

CIDRAP: Encouraging Results Found For MDR-TB Treatment In Pregnant Women

A systematic review and analysis of studies on pregnant women with multidrug-resistant tuberculosis (MDR-TB) found some encouraging results, researchers reported late last week in JAMA Network Open. (6/13)

New England Journal of Medicine: Intramuscular AZD7442 (Tixagevimab–Cilgavimab) For Prevention Of Covid-19

The monoclonal-antibody combination AZD7442 is composed of tixagevimab and cilgavimab, two neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that have an extended half-life and have been shown to have prophylactic and therapeutic effects in animal models. Pharmacokinetic data in humans indicate that AZD7442 has an extended half-life of approximately 90 days. (Levin, M.D., et al, 6/9)

Also —

CIDRAP: Pandemic Policy Changes In Canada Appear To Have Eased Rx Drug Shortages 

Implementation of policy measures in March 2020 in Canada stemmed prescription drug shortages—especially generic drugs—exacerbated by the COVID-19 pandemic, finds an observational study published today in the Canadian Medical Association Journal (CMAJ). ... The authors acknowledged that the reduction in shortages may have stemmed from factors other than the policy changes, such as fewer healthcare visits and reduced demand for drugs amid pandemic restrictions. (Van Beusekom, 6/13)

NerdWallet: How To Afford Your Meds And Support Your Health

The cost of prescription drugs in the U.S. can be enough to make you sick. What you pay varies enormously depending on the drug, the pharmacy, your insurance plan and your deductible, among many other factors. A drug that may have been cheap or at least affordable the last time you filled it could be far more expensive or not covered at all the next time. (Lis Weston, 6/13)

Miami Herald: Miami FL Area Men Get Prison After Drug Coupon Fraud 

Two Kendall men spent seven years — not even pausing during the two years one of them was in prison — raking in $9 million in a scam involving coupons meant to help people pay for prescription drugs. They used friends, wives of friends, shell companies and pharmacies that existed only on paper. (Neal, 6/12)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 22
  • Thursday, May 21
  • Wednesday, May 20
  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF